Estados Unidos

Quiénes somos

  • 5 de abril de 2022
    Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer
  • 5 de abril de 2022
    TAS102 in Combination With NAL-IRI in Advanced GI Cancers
  • 5 de abril de 2022
    Nivolumab+Ipilimumab+RT in MSS mCRC
  • 5 de abril de 2022
    A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
  • 5 de abril de 2022
    Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver
  • 5 de abril de 2022
    Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
  • 5 de abril de 2022
    TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
  • 5 de abril de 2022
    REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors
  • 5 de abril de 2022
    Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
  • 5 de abril de 2022
    Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer